RetinaLyze International

RetinaLyze International Safe, fast and efficient retinal investigations with RetinaLyze AI and Telemedicine. Retinalyze is based on the vision to prevent loss of eyesight.

Worldwide diabetes is an increasing problem and +300 million registered diabetics (type 1 or 2) are expected in 2020. Furthermore by 2020 +250 million unregistered diabetics are expected. One of the most feared consequences of diabetes is retinal diabetic pathology since this can lead to blindness. Early diagnosis is crucial – and possible with Retinalyze. A good diabetic plan and a non-complicated laser treatment can prevent loss of sight and blindness. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions. Retinalyze System A/S is a registered company in Denmark.

Come visit RetinaLyze DACH at stand C4 / 263! We’re presenting:- a new, clearer PDF report that makes communication wit...
16/01/2026

Come visit RetinaLyze DACH at stand C4 / 263!

We’re presenting:
- a new, clearer PDF report that makes communication with patients and ophthalmologists easier
- a brand-new glaucoma feature: 3D insights into the optic nerve head from standard fundus images
- an AI workflow that keeps the optometrist as the first point of contact, supported by a backup ophthalmologist network

👓 Meet Kevin & Patrick Körbs, opticians using RetinaLyze every day, sharing real-world experience from their practice.

🤝 On site with the RetinaLyze D-A-CH team, Michael and Barbara Anthonsen, and our partners, including LikoMed GmbH.

16/01/2026

Come visit RetinaLyze DACH at stand C4 / 263!

We’re presenting:
- a new, clearer PDF report that makes communication with patients and ophthalmologists easier
- a brand-new glaucoma feature: 3D insights into the optic nerve head from standard fundus images
- an AI workflow that keeps the optometrist as the first point of contact, supported by a backup ophthalmologist network

👓 Meet Kevin & Patrick Körbs, opticians using RetinaLyze every day, sharing real-world experience from their practice.

🤝 On site with the RetinaLyze D-A-CH team, Michael and Barbara Anthonsen, and our partners, including LikoMed GmbH.

15/01/2026

Michael Anthonsen and Barbara Anthonsen Wohlgemuth from RetinaLyze DACH look forward to welcoming you at Hall C4 Stand 263 at opti tomorrow!

AI in eye screening should strengthen optometrists - not replace them.That’s exactly what RetinaLyze is showing at opti ...
14/01/2026

AI in eye screening should strengthen optometrists - not replace them.

That’s exactly what RetinaLyze is showing at opti 2026 in Munich.

At Stand C4 / 263, we’re presenting:
- a new, clearer PDF report that makes communication with patients and ophthalmologists easier
- a brand-new glaucoma feature: 3D insights into the optic nerve head from standard fundus images
- an AI workflow that keeps the optometrist as the first point of contact, supported by a backup ophthalmologist network

👓 Meet Kevin & Patrick Körbs, opticians using RetinaLyze every day, sharing real-world experience from their practice.

🤝 On site with the RetinaLyze DACH team, Michael Anthonsen and Barbara Anthonsen Wohlgemuth, and our partners, including LikoMed GmbH.

You’ll also find RetinaLyze at:
OCULUS Optikgeräte GmbH, Topcon Deutschland Medical, Mediconsult AG, Rupp + Hubrach Optik GmbH, Breitfeld & Schliekert GmbH, OPTIC-HANDEL FRAGSTEIN

If you’re curious how AI can support your expertise and workflow, come by and see it live!

📍 opti 2026 | Stand C4 / 263

12/01/2026

The RetinaLyze Glaucoma 3D overlay is launching at opti 2026 this week!

The best news is that the feature will be made available for all customers at no additional cost. 😁

Visit us at booth 263 in Hall C4 to witness the new RetinaLyze 3D glaucoma AI live.

Michael Anthonsen and Barbara Anthonsen Wohlgemuth from RetinaLyze DACH will be there to greet you.

See you at !

Make sure that patients understand what’s happening.At RetinaLyze, we see this issue every day in clinics using AI-suppo...
07/01/2026

Make sure that patients understand what’s happening.

At RetinaLyze, we see this issue every day in clinics using AI-supported screening.

The technology may be advanced, but the conversation with the patient has to stay simple, human, and reassuring.

What works in practice?
• Explain AI as decision support, not a decision maker
• Use everyday analogies – “a second pair of trained eyes”
• Be clear that the clinician remains fully responsible
• Show results visually and relate them to the specific patient
• Invite questions - curiosity builds trust

Patients don’t need to understand algorithms. They need to understand why the tool helps their care.

When clinicians communicate AI with confidence and transparency, something interesting happens:

AI strengthens the clinician-patient relationship without distancing the patient.

Is there a better way to start the year than with one of the most fun events in our industry? 2026 in Munich is exactly...
05/01/2026

Is there a better way to start the year than with one of the most fun events in our industry? 2026 in Munich is exactly that and we can’t wait! 🎉

From January 16–18, optician and optometrists from around the world will come together at the international trade show for optics & design.

📍 Meet us at OPTI 2026
Michael Anthonsen and Anthonsen Wohlgemuth from RetinaLyze DACH will be presenting cutting-edge advances in AI-powered eye screening and clinical support that help optometrists and ophthalmologists deliver faster, safer, and more effective patient care.

For a teaser, visit our OPTI page: https://www.opti.de/de/p/retinalyze-system-switzerland-gmbh.136406

Whether you’re focused on early detection workflows, telemedicine integration, or boosting clinical confidence with reliable AI results, we’ve got you covered!

Looking forward to connecting with colleagues, partners, and new faces. See you in Munich!

New year. New resolutions.We often promise ourselves to eat better, move more, and slow down.But one resolution is often...
31/12/2025

New year. New resolutions.

We often promise ourselves to eat better, move more, and slow down.
But one resolution is often overlooked – eye health.

A simple visit to your optometrist can help detect eye disease early, protect vision, and give peace of mind. Many conditions are silent until it’s too late.

In 2026, make eye care part of your health routine.

Your future self will thank you!

From all of us at RetinaLyze – wishing you a healthy, clear-sighted year ahead. 👀 ✨

29/12/2025

Happy New Year from all of us at RetinaLyze 🎉
Stay safe and protect your eyes!

Happy holidays from RetinaLyze System!
24/12/2025

Happy holidays from RetinaLyze System!

21/12/2025

You may have seen our Merry Christmas video last week, but did you see the bloopers in the end?

Hope you have as much as fun watching it, as we did making it 😂

2025 was a year of real clinical progress for RetinaLyze.Stronger science. Smarter integrations. Broader access to eye s...
17/12/2025

2025 was a year of real clinical progress for RetinaLyze.

Stronger science. Smarter integrations. Broader access to eye screening.

This year we:
- Expanded RetinaLyze Advanced Glaucoma with combined fundus + perimetry analysis
- Strengthened the scientific foundation behind GDF and ONH Hb with large-scale validation
- Deepened integrations with partners like Medibrix and Heidelberg Engineering
- Expanded clinical adoption through new and growing distribution partnerships across Europe and Latin America

Most importantly, everything we built in 2025 was aimed at one goal:
Making early, accessible eye-disease detection work in real clinical workflows.

We’ve wrapped the highlights, evidence, and what’s next into a short Year in Review blog post.

👉 Read it here: https://retinalyze.com/company-news/retinalyze-year-in-review-2025-a-year-of-strong-science-new-integrations-global-momentum/

Thank you to all clinicians, researchers, distributors, and partners shaping the future of eye screening with us.

Happy holidays!

Adresse

Mileparken 10C
Skovlunde
2740

Åbningstider

Mandag 09:00 - 17:30
Tirsdag 09:00 - 17:30
Onsdag 09:00 - 17:30
Torsdag 09:00 - 17:30
Fredag 09:00 - 17:30

Internet side

Underretninger

Vær den første til at vide, og lad os sende dig en email, når RetinaLyze International sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Praksis

Send en besked til RetinaLyze International:

Genveje

Del

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Prevention of blindness through AI

RetinaLyze prevents loss of eyesight by making eye screening accessible. 80% of all blindness is preventable. Early screening and diagnosis is crucial and possible with Retinalyze'​ automated retinal screening tools and telemedicine solutions. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions.

RetinaLyze® is a screening software, which helps eye care professionals perform screenings for eye diseases in a safe and efficient manner. The automated algorithm (AI) module detects eye diseases by analyzing fundus images. It can be used as a clinical decision support system (CDSS) or as a screening tool in conjunction with the telemedicine module. Retinalyze System A/S is a registered company in Denmark. Check us out at https://RetinaLyze.com.